Intravitreal Bevacizumab to Treat Choroidal Neovascularization following Photodynamic Therapy in Central Serous Choroidopathy

Purpose TO report the anatomic and functional outcome of intravitreal bevacizumab (IVB) to treat choroidal neovascularization (CNV) following photodynamic therapy (PDT) to treat recurrent central serous choroidopathy (CSC). Methods This was an interventional case report in which verteporfin PDT was performed in a case of recurrent CSC. Results Following PDT, the patient developed juxtafoveal CNV that was later treated by IVB, achieving CNV closure and recovery of visual acuity. Conclusions Photodynamic therapy is a useful therapy to treat recurrent CSC, though it may be associated with potentially severe complications such as CNV. Intravitreal bevacizumab seems a good alternative treatment in the management of this condition.

[1]  H. Lehr,et al.  Photodynamic therapy induces selective extravasation of macromolecules: Insights using intravital microscopy. , 2010, Journal of photochemistry and photobiology. B, Biology.

[2]  Seong-Woo Kim,et al.  Retinal pigment epithelial tear after half fluence PDT for serous pigment epithelial detachment in central serous chorioretinopathy. , 2009, Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye.

[3]  M. Mochizuki,et al.  Intravitreal bevacizumab on myopic choroidal neovascularization that was refractory to or had recurred after photodynamic therapy , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.

[4]  T. Lai,et al.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial. , 2008, Ophthalmology.

[5]  K. Bartz-Schmidt,et al.  INFLUENCE OF VERTEPORFIN PHOTODYNAMIC THERAPY ON INFLAMMATION IN HUMAN CHOROIDAL NEOVASCULAR MEMBRANES SECONDARY TO AGE-RELATED MACULAR DEGENERATION , 2007, Retina.

[6]  M. Parodi,et al.  Bevacizumab vs photodynamic therapy for choroidal neovascularization in multifocal choroiditis. , 2003, Archives of ophthalmology.

[7]  R Birngruber,et al.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. , 1999, Archives of ophthalmology.

[8]  W. Lee,et al.  Severe choroidal ischemia following Photodynamic Therapy for pigment epithelial detachment and chronic central serous chorioretinopathy , 2008, Japanese Journal of Ophthalmology.

[9]  G. Cıngıl,et al.  Choroidal neovascularization following photodynamic therapy in a patient with chronic central serous chorioretinopathy. , 2007, Bulletin de la Societe belge d'ophtalmologie.

[10]  J. Català Mora,et al.  Photodynamic Therapy for Chronic Central Serous Chorioretinopathy , 2004 .

[11]  R Birngruber,et al.  Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. , 1999, Archives of ophthalmology.